ZYBERNO
Stock Report
Updated Sep 1, 2026

AGAPE ATP CORPORATION (ATPC)

Healthcare • NASDAQ

$2.36

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
AGAPE ATP CORPORATION (ATPC) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-5.2%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-271.4%)
Return on Capital (Capital Efficiency):CRITICAL (-13.9%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

AGAPE ATP CORPORATION (ATPC) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.36
Market Cap:$2.36M

Valuation Multiples (3)

P/B Ratio:0.11x
P/S Ratio:2.05x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$2.38M

Price Action & Momentum (1)

% of 52-Week High:3.2%
B. Profitability Assessment

Return Metrics (5)

ROA:-4.7%
Reinvestment Rate:0.5%
Fundamental Growth Rate (g):-0.1%

Margin Analysis (3)

Operating Margin Ttm:-271.4%
Net Margin Ttm:-100.2%
Ebitda Margin:-270.3%

TTM Performance (3)

Gross Margin Ttm:55.9%
Operating Margin Ttm:-271.4%
Net Margin Ttm:-100.2%

Yield Metrics (2)

Earnings Yield:-$118.47
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:175.3%
Latest Earnings Filed:2026-08-14

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-15.4%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:8.45x
Quick Ratio:8.44x
Cash Ratio:0.02x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x
Debt-to-Equity Ratio:0.00x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:21,895,248.00
Cash And Cash Equivalents:45,480.00
Long Term Debt:$47.53K
Net Debt:$15.88K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.15M
Linear Growth: -15.4%
📊 Click to view full ATPC Revenue analysis & methodology →
Cost Of Revenue Ttm:$412.85K

Profitability Breakdown (2)

Gross profit TTM: $644.22K
Linear Growth: -24.0%
📊 Click to view full ATPC Gross Profit analysis & methodology →
-$3.13M

Bottom Line Performance (3)

-$1.16M
Income Before Tax:-$1.23M
Ebitda Ttm:-3,114,785.00

Operating Expenses (5)

Operating Expenses:3,771,852.00
R And D Expense:0.00
Sga Expense:3,529,861.00
Income Tax Expense:$13.62K
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:3,235.5%
Ebitda Margin:-270.3%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$25.03M
Current Assets:$24.83M
Ppe Net:440,599.00
Goodwill:0.00
Intangible Assets:$8.29K

Liability Structure (4)

Total Liabilities:2,973,434.00
Current Liabilities:2,939,317.00
Long Term Debt:$47.53K
Short Term Debt:$13.84K

Equity & Capital (3)

Equity:$22.05M
Retained Earnings:-$11.97M
Common Stock:30,000,000,000.00

Working Capital Items (3)

Accounts Receivable:4,366.00
Inventory:21,678.00
Accounts Payable:0.00

Special Items (2)

Contract Liabilities:142,308.00
Stock Based Compensation:0.00
C. Cash Flow Analysis

Operating Activities (2)

-$1.35M-$2.42M

Investment Activities (1)

Investing Cash Flow:-$382.00

Financing Activities (3)

Financing Cash Flow:$496.47K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:23,000,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:12,844.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-2.95
-$2.95
Earnings Per Share Ttm:-$1.15

Revenue & Cash Per Share (2)

Sales Per Share Ttm:1.15
Operating Cash Flow Per Share:-$2.41

Book Value & Capital (2)

Book Value Per Share:$22.04
Cash Per Share:0.05

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.05x
Working Capital Turnover Ttm:0.05x

Receivables Management (2)

Receivables Turnover Ttm:263.97x
Days Sales Outstanding Ttm:1.38

Inventory Management (2)

Inventory Turnover Ttm:19.04x
Days Inventory Outstanding Ttm:19.17

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:1,019.55
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:0.5%
Fundamental Growth Rate (g):-0.1%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-15.4%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-24.0%
Book Value Growth Rate (Linear):100.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:ATPC
Company Name:AGAPE ATP CORPORATION
Sector:Healthcare
Industry:Healthcare Services
Exchange:NASDAQ
Country:Malaysia

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:1.00M
Shares Outstanding Basic:1.00M
Shares Outstanding Diluted:1.00M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 20:25:27 UTC
Data Timestamp:2026-08-22T10:02:13.720514
Scroll to Top